title: Restenosis in a Bare-Metal Stent: Drug-Eluting Balloon or Drug-Eluting Stent?
authors.affiliation: From the Interventional Cardiology Department, San Raffaele Scientific Institute, Milan, Italy (A.C., R.J.J.); EMO-GVM, Centro Cuore Columbus, Milan, Italy (A.C., R.J.J.); and Interventional Cardiology Department, Imperial College London, London, United Kingdom (R.J.J.). info@emocolumbus.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Colombo
authors.affiliation: From the Interventional Cardiology Department, San Raffaele Scientific Institute, Milan, Italy (A.C., R.J.J.); EMO-GVM, Centro Cuore Columbus, Milan, Italy (A.C., R.J.J.); and Interventional Cardiology Department, Imperial College London, London, United Kingdom (R.J.J.).
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Jabbour
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000188:drug therapy; D054855:Drug-Eluting Stents; D000068338:Everolimus; D006801:Humans; D008670:Metals; D017239:Paclitaxel; D020123:Sirolimus / Q000627:therapeutic use; D015607:Stents; D016896:Treatment Outcome
chemical_list: D008670:Metals; D000068338:Everolimus; D017239:Paclitaxel; D020123:Sirolimus
keywords: Editorials; drug-coated balloon; drug-eluting stents; everolimus; follow-up studies; stents